These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 21664307

  • 41. Dasatinib.
    Korashy HM, Rahman AF, Kassem MG.
    Profiles Drug Subst Excip Relat Methodol; 2014; 39():205-37. PubMed ID: 24794907
    [Abstract] [Full Text] [Related]

  • 42. Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design.
    Oruganty K, Kannan N.
    Biochim Biophys Acta; 2013 Jul; 1834(7):1322-9. PubMed ID: 23499783
    [Abstract] [Full Text] [Related]

  • 43. iPhos: a toolkit to streamline the alkaline phosphatase-assisted comprehensive LC-MS phosphoproteome investigation.
    Yang TH, Chang HT, Hsiao ES, Sun JL, Wang CC, Wu HY, Liao PC, Wu WS.
    BMC Bioinformatics; 2014 Jul; 15 Suppl 16(Suppl 16):S10. PubMed ID: 25521246
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.
    Brave M, Goodman V, Kaminskas E, Farrell A, Timmer W, Pope S, Harapanhalli R, Saber H, Morse D, Bullock J, Men A, Noory C, Ramchandani R, Kenna L, Booth B, Gobburu J, Jiang X, Sridhara R, Justice R, Pazdur R.
    Clin Cancer Res; 2008 Jan 15; 14(2):352-9. PubMed ID: 18223208
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Probing small molecule-protein interactions: A new perspective for functional proteomics.
    Lenz T, Fischer JJ, Dreger M.
    J Proteomics; 2011 Dec 10; 75(1):100-15. PubMed ID: 21835278
    [Abstract] [Full Text] [Related]

  • 50. Off-target decoding of a multitarget kinase inhibitor by chemical proteomics.
    Missner E, Bahr I, Badock V, Lücking U, Siemeister G, Donner P.
    Chembiochem; 2009 May 04; 10(7):1163-74. PubMed ID: 19350611
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Characterisation of kinase-selective inhibitors by chemical proteomics.
    Daub H.
    Biochim Biophys Acta; 2005 Dec 30; 1754(1-2):183-90. PubMed ID: 16198161
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Phosphosignature predicts dasatinib response in non-small cell lung cancer.
    Klammer M, Kaminski M, Zedler A, Oppermann F, Blencke S, Marx S, Müller S, Tebbe A, Godl K, Schaab C.
    Mol Cell Proteomics; 2012 Sep 30; 11(9):651-68. PubMed ID: 22617229
    [Abstract] [Full Text] [Related]

  • 58. Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.
    Golkowski M, Vidadala RS, Lombard CK, Suh HW, Maly DJ, Ong SE.
    J Proteome Res; 2017 Mar 03; 16(3):1216-1227. PubMed ID: 28102076
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.